Home » Topics » BioWorld Science

BioWorld Science
RSS

Bio-ADM, a novel biomarker of congestion in acute dyspnea

July 6, 2021

SYNB-1934, optimized live bacterial therapeutic for the treatment of phenylketonuria

July 6, 2021

PTC Therapeutics discloses compounds for familial dysautonomia

July 6, 2021

Vivavision Biotechnology describes new ROCK2 inhibitors

July 6, 2021

Shenzhen Jingtai Technology presents Ret inhibitors

July 6, 2021

Chinese investigators divulge P2X3 receptor antagonists

July 6, 2021

Roche patents new BRAF inhibitors

July 6, 2021

Phase I data for CC-90001 in healthy subjects and in participants with hepatic impairment

July 6, 2021

Model of diastolic dysfunction with preserved ejection fraction developed to test HDAC6 inhibition

July 6, 2021

Dose-dependent weight loss seen in first-in-human study of LY-3437943

July 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...